We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRPL:NASDAQPurple Innovation, Inc. Analysis

Data as of 2026-04-25 - not real-time

$0.64

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Purple Innovation posted a strong earnings surprise and modest revenue growth in the latest quarter, yet the stock remains trapped in a bearish technical environment. The 20‑day moving average sits below the 50‑day average, signaling a downtrend, while the 200‑day average is well above current levels. RSI hovers just under the midpoint, indicating limited momentum, and although the MACD histogram turned positive, the overall trend remains bearish. Price is hovering just above a clear support zone with a nearby resistance ceiling, and volume has been slipping, suggesting waning buying interest. Volatility is unusually high and beta exceeds one, aligning with the "Extreme Greed" sentiment in the market.
Fundamentally, the company continues to generate negative earnings and cash flow despite a 9% year‑over‑year revenue increase. Margins remain in the red and debt levels are sizable relative to cash, but adjusted EBITDA has moved into positive territory, hinting at a potential operational turnaround. The valuation metrics point to a stock that appears undervalued given the substantial upside potential indicated by the upside/downside metric. However, the combination of high volatility, weak liquidity, and a fragile balance sheet elevates overall risk, making any investment thesis highly contingent on the company’s ability to sustain its recent profitability improvements.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical positioning with price near support
  • Decreasing volume and elevated short‑term volatility
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue growth and emerging positive adjusted EBITDA
  • Debt restructuring and cash balance constraints
  • Potential for price breakout above resistance if momentum improves

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant upside potential indicated by upside/downside metric
  • Brand presence in the consumer cyclical sleep market
  • Opportunity for a turnaround if profitability trends continue

Key Metrics & Analysis

Financial Health

Revenue Growth9.10%
Profit Margin-10.97%
P/E Ratio-4.0
ROA-6.34%
P/B Ratio-2.3
Op. Cash Flow$-33830000
Free Cash Flow$-42313124

Technical Analysis

TrendBearish
RSI48.3
Support$0.60
Resistance$0.72
MA 20$0.64
MA 50$0.67
MA 200$0.80
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

Target Price$2.45
Upside/Downside282.22%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.04
Volatility73.71%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.